These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 21954269

  • 41. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.
    Tohme RA, Francois J, Cavallaro KF, Paluku G, Yalcouye I, Jackson E, Wright T, Adrien P, Katz MA, Hyde TB, Faye P, Kimanuka F, Dietz V, Vertefeuille J, Lowrance D, Dahl B, Patel R.
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):28-36. PubMed ID: 29064356
    [Abstract] [Full Text] [Related]

  • 42. Rubella outbreaks following virus importations: the experience of Chile.
    Gallegos D, Olea A, Sotomayor V, González C, Muñoz JC, Ramos M, Espinoza MC, Mendoza G, Torres G, Espiñeira E, Andrade W, Fernández J, Fasce R.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S669-74. PubMed ID: 21954265
    [Abstract] [Full Text] [Related]

  • 43. Measles elimination: progress, challenges and implications for rubella control.
    Cutts FT, Lessler J, Metcalf CJ.
    Expert Rev Vaccines; 2013 Aug 01; 12(8):917-32. PubMed ID: 23984961
    [Abstract] [Full Text] [Related]

  • 44. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday MC, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB.
    Trop Med Int Health; 2014 Sep 01; 19(9):1105-15. PubMed ID: 25041586
    [Abstract] [Full Text] [Related]

  • 45. Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001.
    Lanzieri TM, Segatto TC, Siqueira MM, de Oliviera Santos EC, Jin L, Prevots DR.
    Pediatr Infect Dis J; 2003 Apr 01; 22(4):323-9. PubMed ID: 12690271
    [Abstract] [Full Text] [Related]

  • 46. Putting safety first: ensuring safe vaccination practices during the 2006 rubella campaign in Bolivia.
    Halkyer P, Azurduy R, Fuentes M, Van Dick AM, Ronveaux O.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S718-21. PubMed ID: 21954272
    [Abstract] [Full Text] [Related]

  • 47. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.
    Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF.
    Vaccine; 2013 Dec 17; 32(1):69-73. PubMed ID: 24188751
    [Abstract] [Full Text] [Related]

  • 48. Efforts at rubella elimination in the United States: the impact of hemispheric rubella control.
    Dayan GH, Castillo-Solórzano C, Nava M, Hersh BS, Andrus J, Rodriguez R, Reef SE.
    Clin Infect Dis; 2006 Nov 01; 43 Suppl 3():S158-63. PubMed ID: 16998776
    [Abstract] [Full Text] [Related]

  • 49. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT, Monteiro O, Tabard P, Cliff J.
    Bull World Health Organ; 1994 Nov 01; 72(2):227-31. PubMed ID: 8205642
    [Abstract] [Full Text] [Related]

  • 50. Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil, 2001-2002.
    Soares RC, Siqueira MM, Toscano CM, Maia Mde L, Flannery B, Sato HK, Will RM, Rodrigues RC, Oliveira IC, Barbosa TC, Sá GR, Rego MF, Curti SP, Lemos XR, Morhdieck R, Stürmer D, Oliveira MJ, Barbosa da Silva Junior J, Castillo-Solórzano C, Camacho LA, Luna E.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S729-36. PubMed ID: 21954274
    [Abstract] [Full Text] [Related]

  • 51. National programme for the control of poliomyelitis.
    Sokhey J.
    Indian J Public Health; 1985 Sep 01; 29(3):168-74. PubMed ID: 3835134
    [Abstract] [Full Text] [Related]

  • 52. Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008.
    Khetsuriani N, Imnadze P, Baidoshvili L, Jabidze L, Tatishili N, Kurtsikashvili G, Lezhava T, Laurent E, Martin R.
    Vaccine; 2010 Sep 07; 28(39):6455-62. PubMed ID: 20674880
    [Abstract] [Full Text] [Related]

  • 53. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A, Vincent A, Selvaraj K, Manikandan M.
    Rural Remote Health; 2019 Sep 07; 19(3):5261. PubMed ID: 31529972
    [Abstract] [Full Text] [Related]

  • 54. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Nov 24; 49(46):1048-50, 1059. PubMed ID: 11105768
    [Abstract] [Full Text] [Related]

  • 55. Toward measles elimination in Bahrain--a Middle East country experience.
    Jawad JS, Al-Sayyad AS, Sataih F, Naouri B, Alexander JP.
    J Infect Dis; 2011 Jul 24; 204 Suppl 1():S299-304. PubMed ID: 21666177
    [Abstract] [Full Text] [Related]

  • 56. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
    Esteghamati A, Gouya MM, Keshtkar AA, Mahoney F.
    Vaccine; 2008 Sep 15; 26(39):5058-61. PubMed ID: 18662736
    [Abstract] [Full Text] [Related]

  • 57. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
    Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL.
    Bull World Health Organ; 1997 Sep 15; 75(1):69-80. PubMed ID: 9141752
    [Abstract] [Full Text] [Related]

  • 58. Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    O'Connor P, Jankovic D, Zimmerman L, Ben Mamou M, Reef S.
    MMWR Morb Mortal Wkly Rep; 2021 Jun 11; 70(23):833-839. PubMed ID: 34111057
    [Abstract] [Full Text] [Related]

  • 59. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada.
    Hahné S, Macey J, van Binnendijk R, Kohl R, Dolman S, van der Veen Y, Tipples G, Ruijs H, Mazzulli T, Timen A, van Loon A, de Melker H.
    Pediatr Infect Dis J; 2009 Sep 11; 28(9):795-800. PubMed ID: 19710586
    [Abstract] [Full Text] [Related]

  • 60. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul 11; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.